Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1429144

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1429144

LAMEA Mycoplasma Testing Market Size, Share & Trends Analysis Report By Product & Service (Kits & Reagents, Instruments and Services), By Technology, By Application, By End User, By Country and Growth Forecast, 2023 - 2030

PUBLISHED:
PAGES: 129 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Latin America, Middle East and Africa Mycoplasma Testing Market would witness market growth of 14.5% CAGR during the forecast period (2023-2030).

The market has seen a trend towards increased automation and adopting high-throughput technologies. Automated systems offer advantages such as higher efficiency, reduced turnaround times, and lower risk of contamination, making them appealing for laboratories dealing with many samples. There has been a growing interest in point-of-care testing for mycoplasma. Point-of-care devices offer rapid on-site testing capabilities, allowing quick decision-making and immediate corrective actions. This trend is particularly relevant in industries where real-time results are critical.

Advanced methods for this testing have led to incorporation due to ongoing developments in molecular biology. The heightened sensitivity and precision of digital polymerase chain reaction (PCR) and next-generation sequencing (NGS) in identifying mycoplasma contamination are being explored. The development and adoption of novel detection methods have been a notable trend. This includes exploring CRISPR-based technologies for mycoplasma detection, offering high specificity and sensitivity. These innovative approaches aim to improve accuracy and efficiency in identifying mycoplasma contamination.

The biopharmaceutical industry in Saudi Arabia may increasingly recognize the risks posed by mycoplasma contamination in cell cultures used for production. Academic and research institutions in Saudi Arabia may become more proactive in addressing mycoplasma contamination risks in their laboratories. The growing awareness can lead to the incorporation of this testing as a routine practice in research settings to maintain the integrity of experiments and data in Saudi Arabia. As awareness of mycoplasma contamination risks expands, healthcare professionals and researchers involved in cell-based therapies and regenerative medicine applications in Saudi Arabia may prioritize this testing to safeguard the safety and efficacy of patient-specific cell lines. Therefore, due to these aspects, the market will expand across the LAMEA region in upcoming years.

The Brazil market dominated the LAMEA Mycoplasma Testing Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $32.7 million by 2030. The Argentina market is showcasing a CAGR of 15.1% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 14.2% during (2023 - 2030).

Based on Product & Service, the market is segmented into Kits & Reagents, Instruments and Services. Based on Technology, the market is segmented into PCR, ELISA, Microbial Culture Techniques, and Enzymatic Methods. Based on Application, the market is segmented into Cell Line Testing, Virus Testing, End of Production Cells Testing, and Others. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, Cell Banks, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

  • Charles River Laboratories International, Inc.
  • Thermo Fisher Scientific, Inc.
  • Eurofins Scientific SE
  • Lonza Group Ltd.
  • Bio-Rad Laboratories, Inc.
  • InvivoGen SAS
  • Asahi Kasei Corporation
  • F. Hoffmann-La Roche Ltd.
  • Norgen Biotek Corp.
  • PromoCell GmbH

LAMEA Mycoplasma Testing Market Report Segmentation

By Product & Service

  • Kits & Reagents
  • Instruments
  • Services

By Technology

  • PCR
  • ELISA
  • Microbial Culture Techniques
  • Enzymatic Methods

By Application

  • Cell Line Testing
  • Virus Testing
  • End of Production Cells Testing
  • Others

By End User

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Academic Research Institutes
  • Cell Banks
  • Others

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 LAMEA Mycoplasma Testing Market, by Product & Service
    • 1.4.2 LAMEA Mycoplasma Testing Market, by Technology
    • 1.4.3 LAMEA Mycoplasma Testing Market, by Application
    • 1.4.4 LAMEA Mycoplasma Testing Market, by End User
    • 1.4.5 LAMEA Mycoplasma Testing Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
  • 3.3 Porter Five Forces Analysis

Chapter 4. LAMEA Mycoplasma Testing Market by Product & Service

  • 4.1 LAMEA Kits & Reagents Market by Country
  • 4.2 LAMEA Instruments Market by Country
  • 4.3 LAMEA Services Market by Country

Chapter 5. LAMEA Mycoplasma Testing Market by Technology

  • 5.1 LAMEA PCR Market by Country
  • 5.2 LAMEA ELISA Market by Country
  • 5.3 LAMEA Microbial Culture Techniques Market by Country
  • 5.4 LAMEA Enzymatic Methods Market by Country

Chapter 6. LAMEA Mycoplasma Testing Market by Application

  • 6.1 LAMEA Cell Line Testing Market by Country
  • 6.2 LAMEA Virus Testing Market by Country
  • 6.3 LAMEA End of Production Cells Testing Market by Country
  • 6.4 LAMEA Others Market by Country

Chapter 7. LAMEA Mycoplasma Testing Market by End User

  • 7.1 LAMEA Pharmaceutical & Biotechnology Companies Market by Country
  • 7.2 LAMEA Contract Research Organizations Market by Country
  • 7.3 LAMEA Academic Research Institutes Market by Country
  • 7.4 LAMEA Cell Banks Market by Country
  • 7.5 LAMEA Others Market by Country

Chapter 8. LAMEA Mycoplasma Testing Market by Country

  • 8.1 Brazil Mycoplasma Testing Market
    • 8.1.1 Brazil Mycoplasma Testing Market by Product & Service
    • 8.1.2 Brazil Mycoplasma Testing Market by Technology
    • 8.1.3 Brazil Mycoplasma Testing Market by Application
    • 8.1.4 Brazil Mycoplasma Testing Market by End User
  • 8.2 Argentina Mycoplasma Testing Market
    • 8.2.1 Argentina Mycoplasma Testing Market by Product & Service
    • 8.2.2 Argentina Mycoplasma Testing Market by Technology
    • 8.2.3 Argentina Mycoplasma Testing Market by Application
    • 8.2.4 Argentina Mycoplasma Testing Market by End User
  • 8.3 UAE Mycoplasma Testing Market
    • 8.3.1 UAE Mycoplasma Testing Market by Product & Service
    • 8.3.2 UAE Mycoplasma Testing Market by Technology
    • 8.3.3 UAE Mycoplasma Testing Market by Application
    • 8.3.4 UAE Mycoplasma Testing Market by End User
  • 8.4 Saudi Arabia Mycoplasma Testing Market
    • 8.4.1 Saudi Arabia Mycoplasma Testing Market by Product & Service
    • 8.4.2 Saudi Arabia Mycoplasma Testing Market by Technology
    • 8.4.3 Saudi Arabia Mycoplasma Testing Market by Application
    • 8.4.4 Saudi Arabia Mycoplasma Testing Market by End User
  • 8.5 South Africa Mycoplasma Testing Market
    • 8.5.1 South Africa Mycoplasma Testing Market by Product & Service
    • 8.5.2 South Africa Mycoplasma Testing Market by Technology
    • 8.5.3 South Africa Mycoplasma Testing Market by Application
    • 8.5.4 South Africa Mycoplasma Testing Market by End User
  • 8.6 Nigeria Mycoplasma Testing Market
    • 8.6.1 Nigeria Mycoplasma Testing Market by Product & Service
    • 8.6.2 Nigeria Mycoplasma Testing Market by Technology
    • 8.6.3 Nigeria Mycoplasma Testing Market by Application
    • 8.6.4 Nigeria Mycoplasma Testing Market by End User
  • 8.7 Rest of LAMEA Mycoplasma Testing Market
    • 8.7.1 Rest of LAMEA Mycoplasma Testing Market by Product & Service
    • 8.7.2 Rest of LAMEA Mycoplasma Testing Market by Technology
    • 8.7.3 Rest of LAMEA Mycoplasma Testing Market by Application
    • 8.7.4 Rest of LAMEA Mycoplasma Testing Market by End User

Chapter 9. Company Profiles

  • 9.1 Charles River Laboratories International, Inc.
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Segmental and Regional Analysis
  • 9.2 Thermo Fisher Scientific, Inc.
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Segmental and Regional Analysis
    • 9.2.4 Research & Development Expenses
    • 9.2.5 SWOT Analysis
  • 9.3 Eurofins Scientific SE
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Regional Analysis
    • 9.3.4 Recent strategies and developments:
      • 9.3.4.1 Product Launches and Product Expansions:
      • 9.3.4.2 Acquisition and Mergers:
    • 9.3.5 SWOT Analysis
  • 9.4 Lonza Group Ltd.
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Segmental and Regional Analysis
    • 9.4.4 Research & Development Expenses
    • 9.4.5 SWOT Analysis
  • 9.5 Bio-Rad laboratories, Inc.
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Segmental and Regional Analysis
    • 9.5.4 Research & Development Expenses
    • 9.5.5 SWOT Analysis
  • 9.6 InvivoGen SAS
    • 9.6.1 Company Overview
    • 9.6.2 SWOT Analysis
  • 9.7 Asahi Kasei Corporation
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Segmental and Regional Analysis
    • 9.7.4 Research & Development Expenses
    • 9.7.5 SWOT Analysis
  • 9.8 F. Hoffmann-La Roche Ltd.
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Segmental and Regional Analysis
    • 9.8.4 Research & Development Expense
    • 9.8.5 SWOT Analysis
  • 9.9 Norgen Biotek Corp.
    • 9.9.1 Company Overview
  • 9.10. PromoCell GmbH
    • 9.10.1 Company Overview
    • 9.10.2 SWOT Analysis

LIST OF TABLES

  • TABLE 1 LAMEA Mycoplasma Testing Market, 2019 - 2022, USD Million
  • TABLE 2 LAMEA Mycoplasma Testing Market, 2023 - 2030, USD Million
  • TABLE 3 LAMEA Mycoplasma Testing Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 4 LAMEA Mycoplasma Testing Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 5 LAMEA Kits & Reagents Market by Country, 2019 - 2022, USD Million
  • TABLE 6 LAMEA Kits & Reagents Market by Country, 2023 - 2030, USD Million
  • TABLE 7 LAMEA Instruments Market by Country, 2019 - 2022, USD Million
  • TABLE 8 LAMEA Instruments Market by Country, 2023 - 2030, USD Million
  • TABLE 9 LAMEA Services Market by Country, 2019 - 2022, USD Million
  • TABLE 10 LAMEA Services Market by Country, 2023 - 2030, USD Million
  • TABLE 11 LAMEA Mycoplasma Testing Market by Technology, 2019 - 2022, USD Million
  • TABLE 12 LAMEA Mycoplasma Testing Market by Technology, 2023 - 2030, USD Million
  • TABLE 13 LAMEA PCR Market by Country, 2019 - 2022, USD Million
  • TABLE 14 LAMEA PCR Market by Country, 2023 - 2030, USD Million
  • TABLE 15 LAMEA ELISA Market by Country, 2019 - 2022, USD Million
  • TABLE 16 LAMEA ELISA Market by Country, 2023 - 2030, USD Million
  • TABLE 17 LAMEA Microbial Culture Techniques Market by Country, 2019 - 2022, USD Million
  • TABLE 18 LAMEA Microbial Culture Techniques Market by Country, 2023 - 2030, USD Million
  • TABLE 19 LAMEA Enzymatic Methods Market by Country, 2019 - 2022, USD Million
  • TABLE 20 LAMEA Enzymatic Methods Market by Country, 2023 - 2030, USD Million
  • TABLE 21 LAMEA Mycoplasma Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 22 LAMEA Mycoplasma Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 23 LAMEA Cell Line Testing Market by Country, 2019 - 2022, USD Million
  • TABLE 24 LAMEA Cell Line Testing Market by Country, 2023 - 2030, USD Million
  • TABLE 25 LAMEA Virus Testing Market by Country, 2019 - 2022, USD Million
  • TABLE 26 LAMEA Virus Testing Market by Country, 2023 - 2030, USD Million
  • TABLE 27 LAMEA End of Production Cells Testing Market by Country, 2019 - 2022, USD Million
  • TABLE 28 LAMEA End of Production Cells Testing Market by Country, 2023 - 2030, USD Million
  • TABLE 29 LAMEA Others Market by Country, 2019 - 2022, USD Million
  • TABLE 30 LAMEA Others Market by Country, 2023 - 2030, USD Million
  • TABLE 31 LAMEA Mycoplasma Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 32 LAMEA Mycoplasma Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 33 LAMEA Pharmaceutical & Biotechnology Companies Market by Country, 2019 - 2022, USD Million
  • TABLE 34 LAMEA Pharmaceutical & Biotechnology Companies Market by Country, 2023 - 2030, USD Million
  • TABLE 35 LAMEA Contract Research Organizations Market by Country, 2019 - 2022, USD Million
  • TABLE 36 LAMEA Contract Research Organizations Market by Country, 2023 - 2030, USD Million
  • TABLE 37 LAMEA Academic Research Institutes Market by Country, 2019 - 2022, USD Million
  • TABLE 38 LAMEA Academic Research Institutes Market by Country, 2023 - 2030, USD Million
  • TABLE 39 LAMEA Cell Banks Market by Country, 2019 - 2022, USD Million
  • TABLE 40 LAMEA Cell Banks Market by Country, 2023 - 2030, USD Million
  • TABLE 41 LAMEA Others Market by Country, 2019 - 2022, USD Million
  • TABLE 42 LAMEA Others Market by Country, 2023 - 2030, USD Million
  • TABLE 43 LAMEA Mycoplasma Testing Market by Country, 2019 - 2022, USD Million
  • TABLE 44 LAMEA Mycoplasma Testing Market by Country, 2023 - 2030, USD Million
  • TABLE 45 Brazil Mycoplasma Testing Market, 2019 - 2022, USD Million
  • TABLE 46 Brazil Mycoplasma Testing Market, 2023 - 2030, USD Million
  • TABLE 47 Brazil Mycoplasma Testing Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 48 Brazil Mycoplasma Testing Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 49 Brazil Mycoplasma Testing Market by Technology, 2019 - 2022, USD Million
  • TABLE 50 Brazil Mycoplasma Testing Market by Technology, 2023 - 2030, USD Million
  • TABLE 51 Brazil Mycoplasma Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 52 Brazil Mycoplasma Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 53 Brazil Mycoplasma Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 54 Brazil Mycoplasma Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 55 Argentina Mycoplasma Testing Market, 2019 - 2022, USD Million
  • TABLE 56 Argentina Mycoplasma Testing Market, 2023 - 2030, USD Million
  • TABLE 57 Argentina Mycoplasma Testing Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 58 Argentina Mycoplasma Testing Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 59 Argentina Mycoplasma Testing Market by Technology, 2019 - 2022, USD Million
  • TABLE 60 Argentina Mycoplasma Testing Market by Technology, 2023 - 2030, USD Million
  • TABLE 61 Argentina Mycoplasma Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 62 Argentina Mycoplasma Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 63 Argentina Mycoplasma Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 64 Argentina Mycoplasma Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 65 UAE Mycoplasma Testing Market, 2019 - 2022, USD Million
  • TABLE 66 UAE Mycoplasma Testing Market, 2023 - 2030, USD Million
  • TABLE 67 UAE Mycoplasma Testing Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 68 UAE Mycoplasma Testing Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 69 UAE Mycoplasma Testing Market by Technology, 2019 - 2022, USD Million
  • TABLE 70 UAE Mycoplasma Testing Market by Technology, 2023 - 2030, USD Million
  • TABLE 71 UAE Mycoplasma Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 72 UAE Mycoplasma Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 73 UAE Mycoplasma Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 74 UAE Mycoplasma Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 75 Saudi Arabia Mycoplasma Testing Market, 2019 - 2022, USD Million
  • TABLE 76 Saudi Arabia Mycoplasma Testing Market, 2023 - 2030, USD Million
  • TABLE 77 Saudi Arabia Mycoplasma Testing Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 78 Saudi Arabia Mycoplasma Testing Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 79 Saudi Arabia Mycoplasma Testing Market by Technology, 2019 - 2022, USD Million
  • TABLE 80 Saudi Arabia Mycoplasma Testing Market by Technology, 2023 - 2030, USD Million
  • TABLE 81 Saudi Arabia Mycoplasma Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 82 Saudi Arabia Mycoplasma Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 83 Saudi Arabia Mycoplasma Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 84 Saudi Arabia Mycoplasma Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 85 South Africa Mycoplasma Testing Market, 2019 - 2022, USD Million
  • TABLE 86 South Africa Mycoplasma Testing Market, 2023 - 2030, USD Million
  • TABLE 87 South Africa Mycoplasma Testing Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 88 South Africa Mycoplasma Testing Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 89 South Africa Mycoplasma Testing Market by Technology, 2019 - 2022, USD Million
  • TABLE 90 South Africa Mycoplasma Testing Market by Technology, 2023 - 2030, USD Million
  • TABLE 91 South Africa Mycoplasma Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 92 South Africa Mycoplasma Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 93 South Africa Mycoplasma Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 94 South Africa Mycoplasma Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 95 Nigeria Mycoplasma Testing Market, 2019 - 2022, USD Million
  • TABLE 96 Nigeria Mycoplasma Testing Market, 2023 - 2030, USD Million
  • TABLE 97 Nigeria Mycoplasma Testing Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 98 Nigeria Mycoplasma Testing Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 99 Nigeria Mycoplasma Testing Market by Technology, 2019 - 2022, USD Million
  • TABLE 100 Nigeria Mycoplasma Testing Market by Technology, 2023 - 2030, USD Million
  • TABLE 101 Nigeria Mycoplasma Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 102 Nigeria Mycoplasma Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 103 Nigeria Mycoplasma Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 104 Nigeria Mycoplasma Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 105 Rest of LAMEA Mycoplasma Testing Market, 2019 - 2022, USD Million
  • TABLE 106 Rest of LAMEA Mycoplasma Testing Market, 2023 - 2030, USD Million
  • TABLE 107 Rest of LAMEA Mycoplasma Testing Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 108 Rest of LAMEA Mycoplasma Testing Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 109 Rest of LAMEA Mycoplasma Testing Market by Technology, 2019 - 2022, USD Million
  • TABLE 110 Rest of LAMEA Mycoplasma Testing Market by Technology, 2023 - 2030, USD Million
  • TABLE 111 Rest of LAMEA Mycoplasma Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 112 Rest of LAMEA Mycoplasma Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 113 Rest of LAMEA Mycoplasma Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 114 Rest of LAMEA Mycoplasma Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 115 Key Information - Charles River Laboratories International, Inc.
  • TABLE 116 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 117 Key Information - Eurofins Scientific SE
  • TABLE 118 Key Information -Lonza Group Ltd.
  • TABLE 119 Key Information - Bio-Rad Laboratories, Inc.
  • TABLE 120 Key Information - InvivoGen SAS
  • TABLE 121 Key Information - Asahi Kasei Corporation
  • TABLE 122 Key Information - F. Hoffmann-La Roche Ltd.
  • TABLE 123 Key Information - Norgen Biotek Corp.
  • TABLE 124 Key Information - PromoCell GmbH
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!